Comparison between LMA Protector and Igel for Oropharyngeal Leak Pressure in Laproscopic surgeries

Comparison between LMA Protector and Igel for Oropharyngeal Leak Pressure in adult patients posted for Laproscopic surgeries- one year hospital based Randomised Control Trial. - NILL

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2023/09/057613

Enrollment

Registered

2023-09-14

Start date

Unknown

Completion date

Unknown

Last updated

2023-09-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: O- Medical and Surgical

Interventions

Intervention1: LMA Protector: Patients will be pre-medicated with intravenous Inj. Glycopyrrolate at 0.005mg/kg, Inj. Midazolam at 0.05mg/kg and Inj. Fentanyl at 2mcg/kg. Anaesthesia will be induced w

Eligibility

Inclusion criteria

Inclusion criteria: 1. Surgeries lasting up to 120 min or less 2. American Society of Anaesthesiologist- ASA grade I and II 3. Mallampati grade I and II

Exclusion criteria

Exclusion criteria: 1. Upper airway obstruction. 2. Potential difficult intubation

Design outcomes

Primary

Measure	Time frame
To compare Oropharyngeal leak pressure of Igel vs LMA Protector in patients posted for laproscopic surgeriesTimepoint: 5 minutes before and 5 minutes after pneumoperitoneum	—

Secondary

Measure	Time frame
To compare Insertion time and Ease of insertion of Igel vs LMA Protector in patients posted for laproscopic surgeries.Timepoint: During insertion of the device	—

Countries

India

Contacts

Public ContactDr Chaitanya A Kamat

Jawaharlal Nehru Medical College, Belgaum

drchaitanya12@gmail.com8150038305

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026